Adjustable DNA 'shield' can control timing and rate at which mRNA produces proteins in vivo

RNA, widely known from the COVID-19 vaccine, is not actually a "therapeutic agent," but a technology that delivers the ...
The Scientist

The Evolution of Chromatin Immunoprecipitation: A Revolution in DNA-Protein Interaction Studies

In the early 1980s, David Gilmour, now an emeritus biochemistry and molecular biology professor at Pennsylvania State University, joined the laboratory of geneticist and biochemist John Lis as a ...